HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1
- 18 April 2021
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 60 (6) , 413-426
Abstract
Ours and other previous studies have shown that CYP4Z1 is specifically and highly expressed in breast cancer, and acts as a promoter for the stemness of breast cancer cells. Here, we explored whether targeting CYP4Z1 could attenuate the stemness of breast cancer cells using HET0016, which has been confirmed to be an inhibitor of CYP4Z1 by us and others. Using the transcriptome‐sequencing analysis, we found that HET0016 suppressed the expression of cancer stem cell (CSC) markers and stem cell functions. Additionally, HET0016 indeed reduced the stemness of breast cancer cells, as evident by the decrease of stemness marker expression, CD44+/CD24− subpopulation with stemness, mammary‐spheroid formation, and tumor‐initiating ability. Moreover, HET0016 suppressed the metastatic capability through in vitro and in vivo experiments. Furthermore, we confirmed that HET0016 suppressed CYP4Z1 activity, and HET0016‐induced inhibition on the stemness and metastasis of breast cancer cells was rescued by CYP4Z1 overexpression. Thus, our results demonstrate that HET0016 can attenuate the stemness of breast cancer cells through targeting CYP4Z1.Keywords
Funding Information
- National Natural Science Foundation of China (81702957)
This publication has 43 references indexed in Scilit:
- The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1Breast Cancer Research and Treatment, 2015
- HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in MicePLOS ONE, 2014
- Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibitionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2014
- The protective effect of HET0016 on brain edema and blood–brain barrier dysfunction after cerebral ischemia/reperfusionBrain Research, 2014
- Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceAutophagy, 2013
- Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancerToxicology and Applied Pharmacology, 2012
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- Inhibitors of Cytochrome P450 4A Suppress Angiogenic ResponsesThe American Journal of Pathology, 2005
- Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast CarcinomaCancer Research, 2004
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsGenes & Development, 2003